Yesterday, Feb. 2, 2016, 51 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $704.60 to $1,889,600.00.

Highlighted Stocks Traded by Insiders:

Talmer Bancorp (TLMR) - FREE Research Report

Klaeser Dennis L, who is Chief Financial Officer at Talmer Bancorp, bought 64,800 shares at $16.16 on Feb. 2, 2016. Following this transaction, the Chief Financial Officer owned 153,350 shares meaning that the stake was boosted by 73.18% with the 64,800-share transaction.

The shares most recently traded at $15.76, down $0.40, or 2.54% since the insider transaction. Historical insider transactions for Talmer Bancorp go as follows:

  • 4-Week # shares sold: 56,796
  • 12-Week # shares sold: 56,796
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 56,796

The average volume for Talmer Bancorp has been 459,500 shares per day over the past 30 days. Talmer Bancorp has a market cap of $1.1 billion and is part of the financial sector and banking industry. Shares are down 10.05% year-to-date as of the close of trading on Tuesday.

Talmer Bancorp, Inc., through its subsidiaries, provides various commercial and retail banking products and services to small and medium-sized businesses, and individuals in the United States. The stock currently has a dividend yield of 1.24%. The company has a P/E ratio of 20.2. Currently, there are 2 analysts who rate Talmer Bancorp a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TLMR - FREE

TheStreet Quant Ratings rates Talmer Bancorp as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, expanding profit margins and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and premium valuation. Get the full Talmer Bancorp Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Time Warner Cable (TWC) - FREE Research Report

Wayne Pace, who is Director at Time Warner Cable, sold 3,792 shares at $184.45 on Feb. 2, 2016. Following this transaction, the Director owned 25,309 shares meaning that the stake was reduced by 13.03% with the 3,792-share transaction.

The shares most recently traded at $182.63, down $1.82, or 1% since the insider transaction. Historical insider transactions for Time Warner Cable go as follows:

  • 4-Week # shares sold: 4,325
  • 12-Week # shares sold: 4,325
  • 24-Week # shares sold: 4,325

The average volume for Time Warner Cable has been 1.4 million shares per day over the past 30 days. Time Warner Cable has a market cap of $52.2 billion and is part of the services sector and media industry. Shares are down 1.89% year-to-date as of the close of trading on Tuesday.

Time Warner Cable Inc., together with its subsidiaries, provides video, high-speed data, and voice services in the United States. It operates in three segments: Residential Services, Business Services, and Other Operations. The stock currently has a dividend yield of 1.63%. The company has a P/E ratio of 28.6. Currently, there are 6 analysts who rate Time Warner Cable a buy, 1 analyst rates it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TWC - FREE

TheStreet Quant Ratings rates Time Warner Cable as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, good cash flow from operations, expanding profit margins and notable return on equity. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Time Warner Cable Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Ophthotech (OPHT) - FREE Research Report

Patel Samir Chandrakant, who is President at Ophthotech, sold 20,000 shares at $53.59 on Feb. 2, 2016. Following this transaction, the President owned 260,911 shares meaning that the stake was reduced by 7.12% with the 20,000-share transaction.

The shares most recently traded at $50.79, down $2.80, or 5.51% since the insider transaction. Historical insider transactions for Ophthotech go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 2,000
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 5,000
  • 24-Week # shares bought: 500
  • 24-Week # shares sold: 8,000

The average volume for Ophthotech has been 576,300 shares per day over the past 30 days. Ophthotech has a market cap of $2.0 billion and is part of the health care sector and drugs industry. Shares are down 32.46% year-to-date as of the close of trading on Tuesday.

Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of back of the eye. Currently, there are 7 analysts who rate Ophthotech a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPHT - FREE

TheStreet Quant Ratings rates Ophthotech as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, disappointing return on equity and feeble growth in its earnings per share. Get the full Ophthotech Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.